drugset
drugset / Trial / NCT03415282

Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

NCT03415282 ↗

Phase 1 Unknown 24 enrolled Dermavant Sciences GmbH
NaSingle-groupOpen-labelTreatment

Summary

This is a multicenter, open-label Phase 1b study in pediatric patients age 2-11 years old with extensive atopic dermatitis.

Timeline

Start
2018-02-05
Primary completion
2018-07-24
Completion
2018-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject LOTAMILAST Small molecule 0.5 % Topical

Indications

atopic eczema